Completed PHASE2 INTERVENTIONAL NCT00000322

Tyrosine for Methamphetamine Dependence - 1

Tyrosine for Methamphetamine Dependence

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Amphetamine-Related Disorders

Interventions Tyrosine

Updated 5 times since 2017 Last updated: Jan 11, 2017 Started: Apr 30, 1997 Completion: Dec 31, 2001

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Amphetamine-Related Disorders, this trial is completed. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 5 data snapshots since 1997. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Apr 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States